It was found that eptifibatide nanocapsule delivery can selectively inhibit thrombosis in vitro is similar, which indicated that UK-LSA-CHT, LSA, and UK all had certain therapeutic effects on deep vein thrombosis, and the effect of UK-LSA-CHT nanomedicine was the best [26]. The gene discussed is SLC5A7; the disease is deep vein thrombosis.